MPE-281 | Interleukin Related interleukin-related.com

Product Name :
MPE-281

Search keywords :
CD36

drugId :
null

Target Vo:
Platelet glycoprotein 4

Target Vo Short Name :
CD36

Moa_Name:
Platelet glycoprotein 4 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Mperia Therapeutics Inc

Active Company_Name :
Mperia Therapeutics Inc

Active Indication_Name:
Atherosclerosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etrolizumab supplier
FGFR3 Rabbit mAb Technical Information
Hsp90 beta Antibody: Hsp90 beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Hsp90 beta. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts